3R coordination by Fanconi anemia proteins

Biochimie

Volumn 87, Issue 7, 2005, Pages 647-658

  Macé, Gaëtane ^a   Bogliolo, Massimo ^a   Guervilly, Jean Hugues ^a   Du Villard, Jean Antoine Dugas ^a   Rosselli, Filippo ^a  

^a CNRS   (France)

Author keywords

Cell cycle checkpoints; Chromosome breakage syndromes; DNA repair; Fanconi anemia, cross links

Indexed keywords

ATM PROTEIN; BRCA2 PROTEIN; DNA POLYMERASE; FANCONI ANEMIA PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; RAD51 PROTEIN; SCAFFOLD PROTEIN; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ATAXIA TELANGIECTASIA; BLOOM SYNDROME; CANCER SUSCEPTIBILITY; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL INSTABILITY; CONFERENCE PAPER; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FANCONI ANEMIA; GENE MUTATION; GENETIC STABILITY; HUMAN; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; ULTRAVIOLET RADIATION;

CELL CYCLE; CELL CYCLE PROTEINS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; GENOMIC INSTABILITY; HUMANS; NUCLEAR PROTEINS; SYNDROME;

EID: 21244435102     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biochi.2005.05.003     Document Type: Conference Paper

References (138)

1. N.S. Young, and B.P. Alter Clinical features of Fanconi's anemia W.B. Saunders Aplastic Anemia 1994 Acquired and Inherited Philadelphia 275 309 (chapter 14)
2. B.P. Alter, M.H. Greene, I. Velazquez, and P.S. Rosenberg Cancer in Fanconi anemia Blood 101 2003 2072
3. A.D. Auerbach, B. Adler, and R.S. Chaganti Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method Pediatrics 67 1981 128 135
4. A.D. Auerbach Fanconi anemia diagnosis and the diepoxybutane (DEB) test Exp. Hematol. 21 1993 731 733
5. M.D. Tischkowitz, and S.V. Hodgson Fanconi anaemia J. Med. Genet. 40 2003 1 10
6. F. Rosselli, D. Briot, and P. Pichierri The Fanconi anemia pathway and the DNA interstrand cross-links repair Biochimie 85 2003 1175 1184
7. G. Duckworth-Rysiecki, K. Cornish, C.A. Clarke, and M. Buchwald Identification of two complementation groups in Fanconi anemia Somat. Cell Mol. Genet. 11 1985 35 41
8. H. Joenje, A.B. Oostra, M. Wijker, F.M. di Summa, C.G. van Berkel, M.A. Rooimans, W. Ebell, M. Van Weel, J.C. Pronk, M. Buchwald, and F. Arwert Evidence for at least eight Fanconi anemia genes Am. J. Hum. Genet. 61 1997 940 944
9. M. Levitus, M.A. Rooimans, J. Steltenpool, N.F. Cool, A.B. Oostra, C.G. Mathew, M.E. Hoatlin, Q. Waisfisz, F. Arwert, J.P. De Winter, and H. Joenje Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes Blood 103 2004 2498 2503
10. C.A. Strathdee, A.M. Duncan, and M. Buchwald Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9 Nat. Genet. 1 1992 196 198
11. B.P. Alter Fanconi's anaemia and its variability Br. J. Haematol. 85 1993 9 14
12. L. Faivre, P. Guardiola, C. Lewis, I. Dokal, W. Ebell, A. Zatterale, C. Altay, J. Poole, D. Stones, M.L. Kwee, M. Van Weel-Sipman, C. Havenga, N. Morgan, J. De Winter, M. Digweed, A. Savoia, J. Pronk, T. De Ravel, S. Jansen, H. Joenje, E. Gluckman, C.G. Mathew European Fanconi Anemia Research Group Association of complementation group and mutation type with clinical outcome in Fanconi anemia Blood 96 2000 4064 4070
13. M. Futaki, T. Yamashita, H. Yagasaki, T. Toda, M. Yabe, S. Kato, S. Kato, S. Asano, and T. Nakahata The IVS4 + 4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients Blood 95 2000 1493 1498
14. A.P. Gillio, P.C. Verlander, S.D. Batish, P.F. Giampietro, and A.D. Auerbach Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study Blood 90 1997 105 110
15. The Fanconi anaemia/breast cancer consortium Positional cloning of the Fanconi anaemia group A gene Nat. Genet. 14 1996 324 328
16. J.P. de Winter, Q. Waisfisz, M.A. Rooimans, C.G. van Berkel, L. Bosnoyan-Collins, N. Alon, M. Carreau, O. Bender, I. Demuth, D. Schindler, J.C. Pronk, F. Arwert, H. Hoehn, M. Digweed, M. Buchwald, and H. Joenje The Fanconi anaemia group G gene FANCG is identical with XRCC9 Nat. Genet. 20 1998 281 283
17. J.P. de Winter, M.A. Rooimans, L. van Der Weel, C.G. van Berkel, N. Alon, L. Bosnoyan-Collins, J. De Groot, Y. Zhi, Q. Waisfisz, J.C. Pronk, F. Arwert, C.G. Mathew, R.J. Scheper, M.E. Hoatlin, M. Buchwald, and H. Joenje The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM Nat. Genet. 24 2000 15 16
18. J.P. de Winter, F. Leveille, C.G. van Berkel, M.A. Rooimans, L. van Der Weel, J. Steltenpool, I. Demuth, N.V. Morgan, N. Alon, L. Bosnoyan-Collins, J. Lightfoot, P.A. Leegwater, Q. Waisfisz, K. Komatsu, F. Arwert, J.C. Pronk, C.G. Mathew, M. Digweed, M. Buchwald, and H. Joenje Isolation of a cDNA representing the Fanconi anemia complementation group E gene Am. J. Hum. Genet. 67 2000 1306 1308
19. J.R. Lo Ten Foe, M.A. Rooimans, L. Bosnoyan-Collins, N. Alon, M. Wijker, L. Parker, J. Lightfoot, M. Carreau, D.F. Callen, A. Savoia, N.C. Cheng, C.G. Van Berkel, M.H. Strunk, J.J. Gille, G. Pals, F.A. Kruyt, J.C. Pronk, F. Arwert, M. Buchwald, and H. Joenje Expression cloning of a cDNA for the major Fanconi anaemia gene FAA, Nat. Genet. 14 1996 320 323
20. C. Timmers, T. Taniguchi, J. Hejna, C. Reifsteck, L. Lucas, D. Bruun, M. Thayer, B. Cox, S. Olson, A.D. D'Andrea, R. Moses, and M. Grompe Positional cloning of a novel Fanconi anemia gene, FANCD2 Mol. Cell 7 2001 241 248
21. C.A. Strathdee, H. Gavish, W.R. Shannon, and M. Buchwald Cloning of cDNAs for Fanconi's anaemia by functional complementation Nature 358 1992 434 436
22. A.R. Meetei, M. Levitus, Y. Xue, A.L. Medhurst, M. Zwaan, C. Ling, M.A. Rooimans, P. Bier, M. Hoatlin, G. Pals, J.P. De Winter, W. Wang, and H. Joenje X-linked inheritance of Fanconi anemia complementation group B Nat. Genet. 36 2004 1219 1224
23. A.R. Meetei, J.P. de Winter, A.L. Medhurst, M. Wallisch, Q. Waisfisz, H.J. van de Vrugt, A.B. Oostra, Z. Yan, C. Ling, C.E. Bishop, M.E. Hoatlin, H. Joenje, and W. Wang A novel ubiquitin ligase is deficient in Fanconi anemia Nat. Genet. 35 2003 165 170
24. N.G. Howlett, T. Taniguchi, S. Olson, B. Cox, Q. Waisfisz, C. De Die-Smulders, N. Persky, M. Grompe, H. Joenje, G. Pals, H. Ikeda, E.A. Fox, and A.D. D'Andrea Biallelic inactivation of BRCA2 in Fanconi anemia Sci. 297 2002 606 609
25. S.I. Ahmad, F. Hanaoka, and S.H. Kirk Molecular biology of Fanconi anaemia - an old problem, a new insight Bioessays 24 2002 439 448
26. M. Buchwald, and E. Moustacchi Is Fanconi anemia caused by a defect in the processing of DNA damage? Mutat. Res. 408 1998 75 90
27. S. Fagerlie, M.W. Lensch, Q. Pang, and G.C. Bagby Jr. The Fanconi anemia group C gene product: signaling functions in hematopoietic cells Exp. Hematol. 29 2001 1371 1381
28. G. Pagano, and H. Youssoufian Fanconi anaemia proteins: major roles in cell protection against oxidative damage Bioessays 25 2003 589 595
29. A.D. D'Andrea, and M. Grompe The Fanconi anaemia/BRCA pathway Nat. Rev. Cancer 3 2003 23 34
30. M. Futaki, T. Igarashi, S. Watanabe, S. Kajigaya, A. Tatsuguchi, J. Wang, and J.M. Liu The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage Carcinog. 23 2002 67 72
31. A.R. Venkitaraman Tracing the network connecting BRCA and Fanconi anaemia proteins Nat. Rev. Cancer 4 2004 266 276
32. M. Bogliolo, O. Cabre, E. Callen, V. Castillo, A. Creus, R. Marcos, and J. Surralles The Fanconi anaemia genome stability and tumour suppressor network Mutagen. 17 2002 529 538
33. R.C. Cumming, J. Lightfoot, K. Beard, H. Youssoufian, P.J. O'Brien, and M. Buchwald Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1 Nat. Med. 7 2001 814 820
34. T. Hoshino, J. Wang, M.P. Devetten, N. Iwata, S. Kajigaya, R.J. Wise, J.M. Liu, and H. Youssoufian Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression Blood 91 1998 4379 4386
35. F.A. Kruyt, T. Hoshino, J.M. Liu, P. Joseph, A.K. Jaiswal, and H. Youssoufian Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase Blood 92 1998 3050 3056
36. C. Dufour, A. Corcione, J. Svahn, R. Haupt, V. Poggi, A.N. Beka'ssy, R. Scime, A. Pistorio, and V. Pistoia TNF-α and IFN-γ are overexpressed in the bone marrow of Fanconi anemia patients and TNF-α suppresses erythropoiesis in vitro Blood 102 2003 2053 2059
37. S.R. Fagerlie, J. Diaz, T.A. Christianson, K. McCartan, W. Keeble, G.R. Faulkner, and G.C. Bagby Functional correction of FA-C cells with FANCC suppresses the expression of interferon γ-inducible genes Blood 97 2001 3017 3024
38. Q. Pang, S. Fagerlie, T.A. Christianson, W. Keeble, G. Faulkner, J. Diaz, R.K. Rathbun, and G.C. Bagby The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by γ interferon and hematopoietic growth factors Mol. Cell. Biol. 20 2000 4724 4735
39. Q. Pang, W. Keeble, J. Diaz, T.A. Christianson, S. Fagerlie, K. Rathbun, G.R. Faulkner, M. O'Dwyer, and G.C. Bagby Jr. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon γ, tumor necrosis factor-α, and double-stranded RNA Blood 97 2001 1644 1652
40. Q. Pang, T.A. Christianson, W. Keeble, J. Diaz, G.R. Faulkner, C. Reifsteck, S. Olson, and G.C. Bagby The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality Blood 98 2001 1392 1401
41. Q. Pang, W. Keeble, T.A. Christianson, G.R. Faulkner, and G.C. Bagby FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-γ/TNF-α-mediated cytotoxicity EMBO J. 20 2001 4478 4489
42. Q. Pang, T.A. Christianson, W. Keeble, T. Koretsky, and G.C. Bagby The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC J. Biol. Chem. 277 2002 49638 49643
43. Q. Pang, T.A. Christianson, T. Koretsky, H. Carlson, L. David, W. Keeble, G.R. Faulkner, A. Speckhart, and G.C. Bagby Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR J. Biol. Chem. 278 2003 41709 41717
44. F. Rosselli, J. Sanceau, J. Wietzerbin, and E. Moustacchi Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6 Hum. Genet. 89 1992 42 48
45. F. Rosselli, J. Sanceau, E. Gluckman, J. Wietzerbin, and E. Moustacchi Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor α Blood 83 1994 1216 1225
46. J.C. Schultz, and N.T. Shahidi Tumor necrosis factor-α overproduction in Fanconi's anemia Am. J. Hematol. 42 1993 196 201
47. A.R. Meetei, S. Sechi, M. Wallisch, D. Yang, M.K. Young, H. Joenje, M.E. Hoatlin, and W. Wang A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome Mol. Cell. Biol. 23 2003 3417 3426
48. F. Qiao, A. Moss, and G.M. Kupfer Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner J. Biol. Chem. 276 2001 23391 23396
49. A. Thomashevski, A.A. High, M. Drozd, J. Shabanowitz, D.F. Hunt, P.A. Grant, and G.M. Kupfer The Fanconi anemia core complex forms four complexes of different sizes in different subcellular compartments J. Biol. Chem. 279 2004 26201 26209
50. J. Mi, and G.M. Kupfer The Fanconi anemia core complex associates with chromatin during S phase Blood 105 2005 759 766
51. P.R. Andreassen, A.D. D'Andrea, and T. Taniguchi ATR couples FANCD2 monoubiquitination to the DNA-damage response Genes Dev. 18 2004 1958 1963
52. I. Garcia-Higuera, T. Taniguchi, S. Ganesan, M.S. Meyn, C. Timmers, J. Hejna, M. Grompe, and A.D. D'Andrea Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway Mol. Cell 7 2001 249 262
53. K. Nakanishi, T. Taniguchi, V. Ranganathan, H.V. New, L.A. Moreau, M. Stotsky, C.G. Mathew, M.B. Kastan, D.T. Weaver, and A.D. D'Andrea Interaction of FANCD2 and NBS1 in the DNA damage response Nat. Cell Biol. 4 2002 913 920
54. P. Pichierri, D. Averbeck, and F. Rosselli DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein Hum. Mol. Genet. 11 2002 2531 2546
55. P. Pichierri, and F. Rosselli The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways EMBO J. 23 2004 1178 1187
56. K. Nakanishi, Y.G. Yang, A.J. Pierce, T. Taniguchi, M. Digweed, A.D. D'Andrea, Z.Q. Wang, and M. Jasin Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair Proc. Natl. Acad. Sci. USA 102 2005 1110 1115
57. A. Ohashi, M.Z. Zdzienicka, J. Chen, and F.J. Couch Fanconi Anemia Complementation Group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage J. Biol. Chem. 280 2005 14877 14883
58. P.A. Huber, A.L. Medhurst, H. Youssoufian, and C.G. Mathew Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis Biochem. Biophys. Res. Commun. 268 2000 73 77
59. S.M. Gordon, and M. Buchwald Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems Blood 102 2003 136 141
60. T. Reuter, S. Herterich, O. Bernhard, H. Hoehn, and H.J. Gross Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system Blood 95 2000 719 720
61. Q. Waisfisz, J.P. de Winter, F.A. Kruyt, J. de Groot, L. van der Weel, L.M. Dijkmans, Y. Zhi, F. Arwert, R.J. Scheper, H. Youssoufian, M.E. Hoatlin, and H. Joenje A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA Proc. Natl. Acad. Sci. USA 96 1999 10320 10325
62. I. Garcia-Higuera, Y. Kuang, D. Naf, J. Wasik, and A.D. D'Andrea Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex Mol. Cell. Biol. 19 1999 4866 4873
63. Y. Kuang, I. Garcia-Higuera, A. Moran, M. Mondoux, M. Digweed, and A.D. D'Andrea Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity Blood 96 2000 1625 1632
64. F.A. Kruyt, F. Abou-Zahr, H. Mok, and H. Youssoufian Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain J. Biol. Chem. 274 1999 34212 34218
65. I. Garcia-Higuera, Y. Kuang, J. Denham, and A.D. D'Andrea The Fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex Blood 96 2000 3224 3230
66. T. Otsuki, D.B. Young, D.T. Sasaki, M.P. Pando, J. Li, A. Manning, M. Hoekstra, M.E. Hoatlin, F. Mercurio, and J.M. Liu Fanconi anemia protein complex is a novel target of the IKK signalsome J. Cell. Biochem. 86 2002 613 623
67. T. Yamashita, G.M. Kupfer, D. Naf, A. Suliman, H. Joenje, S. Asano, and A.D. D'Andrea The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation Proc. Natl. Acad. Sci. USA 95 1998 13085 13090
68. M. Futaki, S. Watanabe, S. Kajigaya, and J.M. Liu Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-α treatment Biochem. Biophys. Res. Commun. 281 2001 347 351
69. H. Yagasaki, D. Adachi, T. Oda, I. Garcia-Higuera, N. Tetteh, A.D. D'Andrea, M. Futaki, S. Asano, and T. Yamashita A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA Blood 98 2001 3650 3657
70. T. Otsuki, T. Nagashima, N. Komatsu, K. Kirito, Y. Furukawa, S. Kobayashi Si, J.M. Liu, and K. Ozawa Phosphorylation of Fanconi anemia protein, FANCA, is regulated by Akt kinase Biochem. Biophys. Res. Commun. 291 2002 628 634
71. F. Qiao, J. Mi, J.B. Wilson, G. Zhi, N.R. Bucheimer, N.J. Jones, and G.M. Kupfer Phosphorylation of Fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway J. Biol. Chem. 279 2004 46035 46045
72. J. Mi, F. Qiao, J.B. Wilson, A.A. High, M.J. Schroeder, P.T. Stukenberg, A. Moss, J. Shabanowitz, D.F. Hunt, N.J. Jones, and G.M. Kupfer FANCG is phosphorylated at serines 383 and 387 during mitosis Mol. Cell. Biol. 24 2004 8576 8585
73. G.M. Kupfer, T. Yamashita, D. Naf, A. Suliman, S. Asano, and A.D. D'Andrea The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2 Blood 90 1997 1047 1054
74. J.P. de Winter, L. van der Weel, J. de Groot, S. Stone, Q. Waisfisz, F. Arwert, R.J. Scheper, F.A. Kruyt, M.E. Hoatlin, and H. Joenje The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG Hum. Mol. Genet. 9 2000 2665 2674
75. F. Leveille, E. Blom, A.L. Medhurst, P. Bier, H. Laghmani, M. Johnson, M.A. Rooimans, A. Sobeck, Q. Waisfisz, F. Arwert, K.J. Patel, M.E. Hoatlin, H. Joenje, and J.P. De Winter The Fanconi anemia gene product FANCF is a flexible adaptor protein J. Biol. Chem. 279 2004 39421 39430
76. A.L. Medhurst, P.A. Huber, Q. Waisfisz, J.P. de Winter, and C.G. Mathew Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway Hum. Mol. Genet. 10 2001 423 429
77. P. Pace, M. Johnson, W.M. Tan, G. Mosedale, C. Sng, M. Hoatlin, J. De Winter, H. Joenje, F. Gergely, and K.J. Patel FANCE: the link between Fanconi anaemia complex assembly and activity EMBO J. 21 2002 3414 3423
78. T. Taniguchi, and A.D. D'Andrea The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC Blood 100 2002 2457 2462
79. P. Fei, J. Yin, and W. Wang New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein Cell Cycle 4 2005 80 86
80. A.R. Meetei, Z. Yan, and W. Wang FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination Cell Cycle 3 2004 179 181
81. T. Taniguchi, I. Garcia-Higuera, P.R. Andreassen, R.C. Gregory, M. Grompe, and A.D. D'Andrea S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51 Blood 100 2002 2414 2420
82. T. Taniguchi, I. Garcia-Higuera, B. Xu, P.R. Andreassen, R.C. Gregory, S.T. Kim, W.S. Lane, M.B. Kastan, and A.D. D'Andrea Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways Cell 109 2002 459 472
83. P. Pichierri, A. Franchitto, and F. Rosselli BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks EMBO J. 23 2004 3154 3163
84. M. Koren-Michowitz, E. Friedman, R. Gershoni-Baruch, F. Brok-Simoni, Y. Patael, G. Rechavi, and N. Amariglio Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development Am. J. Hematol. 78 2005 203 206
85. M. Digweed, S. Rothe, I. Demuth, R. Scholz, D. Schindler, M. Stumm, M. Grompe, A. Jordan, and K. Sperling Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia Carcinog. 23 2002 1121 1126
86. B.C. Godthelp, F. Artwert, H. Joenje, and M.Z. Zdzienicka Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1 Oncogene 21 2002 5002 5005
87. J.M. Wong, D. Ionescu, and C.J. Ingles Interaction between BRCA2 and replication protein A is compromised by a cancer-predisposing mutation in BRCA2 Oncogene 22 2003 28 33
88. K. Yoshida, and Y. Miki Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage Cancer Sci. 95 2004 866 871
89. S. Shin, and I.M. Verma BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription Proc. Natl. Acad. Sci. USA 100 2003 7201 7206
90. A.R. Venkitaraman Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108 2002 171 182
91. A.R. Venkitaraman Functions of BRCA1 and BRCA2 in the biological response to DNA damage J. Cell Sci. 114 2001 3591 3598
92. A.A. Davies, J.Y. Masson, M.J. McIlwrait, A.Z. Stasiak, A. Stasiak, A.R. Venkitaraman, and S.C. West Role of BRCA2 in control of the RAD51 recombination and DNA repair protein Mol. Cell 7 2001 273 282
93. S. Hussain, E. Witt, P.A. Huber, A.L. Medhurst, A. Ashworth, and C.G. Mathew Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1 Hum. Mol. Genet. 12 2003 2503 2510
94. S. Hussain, J.B. Wilson, A.L. Medhurst, J. Hejna, E. Witt, S. Ananth, A. Davies, J.Y. Masson, R. Moses, S.C. West, J.P. De Winter, A. Ashworth, N.J. Jones, and C.G. Mathew Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways Hum. Mol. Genet. 13 2004 1241 1248
95. Y. Wang, D. Cortez, P. Yazdi, N. Neff, S.J. Elledge, and J. Qin BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures Genes Dev. 14 2000 927 939
96. S.L. Donahue, C. Campbell, and A. Rad 50-dependent pathway of DNA repair is deficient in Fanconi anemia fibroblasts Nucleic Acids Res. 32 2004 3248 3257
97. D. Sridharan, M. Brown, W.C. Lambert, L.W. McMahon, and M.W. Lambert Nonerythroid α II spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links J. Cell Sci. 116 2003 823 835
98. R.T. Abraham Cell cycle checkpoint signaling through the ATM and ATR kinases Genes Dev. 15 2001 2177 2196
99. R.T. Abraham PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways DNA Repair (Amst.) 3 2004 883 887
100. C.E. Canman, and D.S. Lim The role of ATM in DNA damage responses and cancer Oncogene 17 1998 3301 3308
101. M.F. Lavin, and Y. Shiloh Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transduction Curr. Opin. Immunol. 8 1996 459 464
102. M.F. Lavin, and Y. Shiloh The genetic defect in ataxia-telangiectasia Annu. Rev. Immunol. 15 1997 177 202
103. Y. Shiloh Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart Annu. Rev. Genet. 31 1997 635 662
104. M. O'Driscoll, V.L. Ruiz-Perez, C.G. Woods, P.A. Jeggo, and J.A. Goodship A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome Nat. Genet. 33 2003 497 501
105. G.K. Alderton, H. Joenje, R. Varon, A.D. Borglum, P.A. Jeggo, and M. O'Driscoll Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway Hum. Mol. Genet. 13 2004 3127 3138
106. J. Kobayashi, A. Antoccia, H. Tauchi, S. Matsuura, and K. Komatsu NBS1 and its functional role in the DNA damage response DNA Repair (Amst.) 3 2004 855 861
107. T.T. Paull, and M. Gellert The 3′ to 5′ exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks Mol. Cell 1 1998 969 979
108. I.B. Resnick, I. Kondratenko, O. Togoev, N. Vasserman, I. Shagina, O. Evgrafov, S. Tverskaya, K.M. Cerosaletti, R.A. Gatti, and P. Concannon Nijmegen breakage syndrome: clinical characteristics and mutation analysis in eight unrelated Russian families J. Pediatr. 140 2002 355 361
109. H.V. New, C.M. Cale, M. Tischkowitz, A. Jones, P. Telfer, P. Veys, A. D'Andrea, C.G. Mathew, and I. Hann Nijmegen breakage syndrome diagnosed as Fanconi anaemia Pediatr. Blood Cancer 44 2005 494 499
110. A.R. Gennery, M.A. Slatter, A. Bhattacharya, D. Barge, S. Haigh, M. O'Driscoll, R. Coleman, M. Abinun, T.J. Flood, A.J. Cant, and P.A. Jeggo The clinical and biological overlap between Nijmegen Breakage Syndrome and Fanconi anemia Clin. Immunol. 113 2004 214 219
111. I.M. Ward, and J. Chen Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress J. Biol. Chem. 276 2001 47759 47762
112. O. Fernandez-Capetillo, A. Lee, M. Nussenzweig, and A. Nussenzweig H2AX: the histone guardian of the genome DNA Repair (Amst.) 3 2004 959 967
113. R. Scully, J. Chen, R.L. Ochs, K. Keegan, M. Hoekstra, J. Feunteun, and D.M. Livingston Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage Cell 90 1997 425 435
114. V.P. Yu, M. Koehler, C. Steinlein, M. Schmid, L.A. Hanakahi, A.J. van Gool, S.C. West, and A.R. Venkitaraman Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation Genes Dev. 14 2000 1400 1406
115. M.E. Moynahan, T.Y. Cui, and M. Jasin Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation Cancer Res. 61 2001 4842 4850
116. A. Tutt, D. Bertwistle, J. Valentine, A. Gabriel, S. Swift, G. Ross, D.J. Chen, and P. Hasty Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences EMBO J. 20 2001 4704 4716
117. J. Su, and K. Ciftci Changes in BRCA1 and BRCA2 expression produced by chemotherapeutic agents in human breast cancer cells Int. J. Biochem. Cell Biol. 34 2002 950 957
118. G. Donoho, M.A. Brenneman, T.X. Cui, D. Donoviel, H. Vogel, E.H. Goodwin, D.J. Chen, and P. Hasty Deletion of Brca2 exon 27 causes hypersensitivity to DNA crosslinks, chromosomal instability, and reduced life span in mice Genes Chromosomes Cancer 36 2003 317 331
119. J. Shorrocks, S.E. Tobi, H. Latham, J.H. Peacock, R. Eeles, D. Eccles, and T.J. McMillan Primary fibroblasts from BRCA1 heterozygotes display an abnormal G1/S cell cycle checkpoint following UVA irradiation but show normal levels of micronuclei following oxidative stress or mitomycin C treatment Int. J. Radiat. Oncol. Biol. Phys. 58 2004 470 478
120. J. Yun, Q. Zhong, J.Y. Kwak, and W.H. Lee Hypersensitivity of Brca1-deficient MEF to the DNA interstrand crosslinking agent mitomycin C is associated with defect in homologous recombination repair and aberrant S-phase arrest Oncogene 2005 (in press)
121. M. Jasin Homologous repair of DNA damage and tumorigenesis: the BRCA connection Oncogene 21 2002 8981 8993
122. A. Bhattacharyya, U.S. Ear, B.H. Koller, R.R. Weichselbaum, and D.K. Bishop The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin J. Biol. Chem. 275 2000 23899 23903
123. M.E. Moynahan, J.W. Chiu, B.H. Koller, and M. Jasin Brca1 controls homology-directed DNA repair Mol. Cell 4 1999 511 518
124. H. Joenje, and F. Arwert Connecting Fanconi anemia to BRCA1 Nat. Med. 7 2001 406 407
125. N.A. Ellis, and J. German Molecular genetics of Bloom's syndrome Hum. Mol. Genet. 5 1996 1457 1463
126. A.J. van Brabant, R. Stan, and N.A. Ellis DNA helicases, genomic instability, and human genetic disease Annu. Rev. Genom. Hum. Genet. 1 2000 409 459
127. I.D. Hickson, S.L. Davies, J.L. Li, N.C. Levitt, P. Mohaghegh, P.S. North, and L. Wu Role of the Bloom's syndrome helicase in maintenance of genome stability Biochem. Soc. Trans. 29 2001 201 204
128. N.A. Ellis, J. Groden, T.Z. Ye, J. Straughen, D.J. Lennon, S. Ciocci, M. Proytcheva, and J. German The Bloom's syndrome gene product is homologous to RecQ helicases Cell 83 1995 655 666
129. A. Franchitto, and P. Pichierri Protecting genomic integrity during DNA replication: correlation between Werner's and Bloom's syndrome gene products and the MRE11 complex Hum. Mol. Genet. 11 2002 2447 2453
130. A. Franchitto, and P. Pichierri Bloom's syndrome protein is required for correct relocalization of RAD50/MRE11/NBS1 complex after replication fork arrest J. Cell Biol. 157 2002 19 30
131. D.J. Mustra, A.J. Warren, and J.W. Hamilton Preferential binding of human full-length XPA and the minimal DNA binding domain (XPA-MF122) with the mitomycin C-DNA interstrand cross-link Biochem. 40 2001 7158 7164
132. P.J. McHugh, V.J. Spanswick, and J.A. Hartley Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance Lancet Oncol. 2 2001 483 490
133. L.J. Niedernhofer, J. Essers, G. Weeda, B. Beverloo, J. de Wit, M. Muijtjens, H. Odijk, J.H. Hoeijmakers, and R. Kanaar The structure-specific endonuclease Ercc1-Xpf is required for targeted gene replacement in embryonic stem cells EMBO J. 20 2001 6540 6549
134. N. Zhang, X. Zhang, C. Peterson, L. Li, and R. Legerski Differential processing of UV mimetic and interstrand crosslink damage by XPF cell extracts Nucleic Acids Res. 28 2000 4800 4804
135. J.M. Prasher, A.S. Lalai, C. Heijmans-Antonissen, R.E. Ploemacher, J.H. Hoeijmakers, I.P. Touw, and L.J. Niedernhofer Reduced hematopoietic reserves in DNA interstrand crosslink repair-deficient Ercc1-/- mice EMBO J. 24 2005 861 871
136. M. Sala-Trepat, D. Rouillard, M. Escarceller, A. Laquerbe, E. Moustacchi, and D. Papadopoulo Arrest of S-phase progression is impaired in Fanconi anemia cells Exp. Cell Res. 260 2000 208 215
137. P. Pichierri, and F. Rosselli Fanconi anemia proteins and the s phase checkpoint Cell Cycle 3 2004 698 700
138. S.A. Centurion, H.R. Kuo, and W.C. Lambert Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent Exp. Cell Res. 260 2000 216 221